Skip to main content

Featured

TSX Down About 8% in a Week: Should You Tax-Loss Sell Before the Dec. 30 Deadline?

  Canadian Money Brief • Year-End Tax Planning • Nov. 21, 2026 If you opened your brokerage app this week and winced, you are not alone. The S&P/TSX composite closed Friday at 33,189.85, down 838.88 points (about 2.5%) on the day, according to The Canadian Press. A week earlier it closed at 36,105.90, so the index has shed roughly 8% in five trading days. South of the border, the AP reported the S&P 500 fell 3.7% on Friday for its worst weekly loss in more than 18 months, while the Nasdaq slid into negative territory for the year. Painful? Yes. But if you hold investments in a non-registered account, a falling market also hands you a tax tool: tax-loss selling . Used carefully, it can turn a paper loss into a lower tax bill. Used carelessly, it can leave you with no tax benefit at all, or with a portfolio that no longer matches your plan. Here is how it works and what to check before the deadline. THE DEADLINE: Wednesday, Dec. 30, 2026 is the last trading day for most Cana...

article

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.
  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.
  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.
  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.
  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Comments